814 filings
Page 2 of 41
DEFA14A
p92okx736oh 0fhv
2 Jan 24
Additional proxy soliciting materials
8:10am
EFFECT
9uoh4to6ry
28 Dec 23
Notice of effectiveness
12:15am
DEFA14A
82sqp2 y9aq1dzsj7j
22 Dec 23
Additional proxy soliciting materials
4:01pm
DEFA14A
6ho pb6ly5j8u
22 Dec 23
Additional proxy soliciting materials
8:10am
UPLOAD
cm2czky1qg
21 Dec 23
Letter from SEC
12:00am
CORRESP
fcarfp7td 4hux0f
21 Dec 23
Correspondence with SEC
12:00am
DEFA14A
xm7vrsd5n 8ygroh01s
20 Dec 23
Additional proxy soliciting materials
4:59pm
DEFA14A
7bmae t7voh
20 Dec 23
Additional proxy soliciting materials
4:54pm
8-K
459g4 8d2
1 Dec 23
Seelos Therapeutics Announces Closing of Public Offering
4:08pm
8-K
4oanp kzku1x0febwc
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
ga74ux6 iaha3m322
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
fiw7q3o6212r
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B3
p4b4g0wbfqwsxpv ia0g
28 Nov 23
Prospectus supplement
4:03pm
8-K
84kx6si8vq e6efr3
28 Nov 23
Material Modifications to Rights of Security Holders
9:00am
8-K
sztny53zgxk1nny me9
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
12:07pm
8-K
a8mhl8xodsn9iqxi4q
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
11:10am